Because tumor‐associated axonogenesis, which manifests as increased nerve density,[8] represents the initial step that drives neuroplasticity and PNI, we conducted further analyses to determine whether KRAS is involved in axonogenesis in PDAC. The gene discussed is KRAS; the disease is neoplasm.